ArticlePhilosophy, ethics, and humanities in medicine : PEHM2025
Being a woman researcher in dangerous laboratories: biosafety level 3 and tuberculosis.
Article in Philosophy, ethics, and humanities in medicine : PEHM, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStudies on the tuberculosis pathogen Mycobacterium tuberculosis bacillus require a biosafety level 3 laboratory. This study aims to investigate the gender distribution of researchers working in the most hazardous tuberculosis laboratory.
methodsIn this study, the original articles indexed in Web of Science between 1970 and 2021, which include phenotypic testing methods in which the susceptibility results of drugs used in the treatment of tuberculosis are determined, were reviewed.
resultsAs a result of our analysis, it was found that female researchers were included as first name in the publications at a rate of 49%, unlike other fields of science, and 51% came from lower-middle-income and upper-middle-income countries. According to the incidence rates announced by the World Health Organization in the years when the articles were published, it was seen that female researchers participated in more studies in regions with a high incidence of tuberculosis to ('x̄' = 89.94).
conclusionAccording to our data, it was found that the proportion of female researchers was high in the laboratory with a high risk of contamination of biosafety level 3. The high proportion of female researchers in hazardous areas is striking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.